1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Press Releases
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
Real-time Estimate Cboe Europe  -  03:43 2022-07-05 am EDT
321.88 CHF   -0.22%
07/01Pharmaceutical companies still have the upper hand
06/29GLOBAL MARKETS LIVE : Novartis, Tesla, Disney, Sony, Walmart...
06/29ROCHE HOLDINGS AG : JP Morgan remains Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
06/23Galderma Announces Topline Results of OLYMPIA 2 Study Evaluating Nemolizumab in Prurigo..
AQ
06/21KENYA : Ministry signs agreement to enhance access to breast cancer treatment
AQ
06/21KENYA : Ministry signs agreement to enhance access to breast cancer treatment Breast cance..
AQ
06/17Nordic Bioscience and Roche Diagnostics Strengthen Collaboration for Development of Bio..
AQ
06/16Roche provides update on Alzheimer's Prevention Initiative study evaluating crenezumab ..
AQ
06/16Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical ca..
AQ
06/16Genentech Provides Update on Alzheimer's Prevention Initiative Study Evaluating Crenezu..
BU
06/16Roche provides update on Alzheimer's Prevention Initiative study evaluating crenezumab ..
GL
06/15Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously d..
AQ
06/13Roche announces positive data from broad blood cancer portfolio at European Hematology ..
AQ
06/10Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematol..
BU
06/09U.S. FDA approves Foundation Medicine's FoundationOne®CDx as a companion diagnostic for..
AQ
06/09European Commission approves Roche's Tecentriq as adjuvant treatment for a subset of pe..
GL
06/08Kazia Therapeutics Limited - PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES T..
AQ
06/08Chugai Receives DX Grand Prix 2022 Awards in Digital Transformation Stocks (DX Stocks) ..
AQ
06/08European Commission approves Roche's first-in-class bispecific antibody Lunsumio for pe..
GL
06/07GBT's Inclacumab and GBT601 Receive U.S. FDA Orphan Drug and Rare Pediatric Disease Des..
AQ
06/07Chugai Supports the Japan Climate Initiative's Calling to Raise Renewable Energy Target
AQ
06/06NEW BPCIA COMPLAINT : Genentech Files Suit Against Tanvex Regarding Its Proposed Herceptin..
AQ
06/06Chugai Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic Profile to be U..
AQ
06/01Beijing IP Court Hears China's First Patent Linkage Case
AQ
05/31PTC Therapeutics, Inc. - FDA Approves Label Extension for Evrysdi for Infants with Spin..
AQ
05/31FDA Approves Genentech's Evrysdi (risdiplam) for Use in Babies Under Two Months With Sp..
BU
05/31FDA approves Roche's Evrysdi for use in babies under two months with spinal muscular at..
AQ
05/27New pivotal data demonstrate clinical benefit of Roche's glofitamab, a potential first-..
GL
05/26New Pivotal Data Demonstrate Clinical Benefit of Genentech's Glofitamab, a Potential Fi..
BU
05/26Chugai Launches Vabysmo Intravitreal Injection 120 mg/mL for the Treatment of Age-relat..
AQ
05/26Roche's Polivy combination approved by European Commission for people with previously u..
AQ
05/25Roche's Polivy combination approved by European Commission for people with previously u..
AQ
05/25Roche develops unique PCR tests to detect the monkeypox virus
AQ
05/25Alembic Pharmaceuticals receives USFDA Final Approval for Pirfenidone Tablets, 267 mg a..
AQ
05/24Data at the 2022 ASCO Annual Meeting Highlight Genentech's Continued Commitment to Inno..
BU
05/24Data at the 2022 ASCO Annual Meeting highlight Roche's continued commitment to innovati..
AQ
05/20Biocon Biologics and Viatris Launch Abevmy (bBevacizumab), Their Third Oncology Biosimi..
AQ
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
05/12Roche enters partnership with the Global Fund to support low- and middle-income countri..
GL
05/11Scandion Oncology enhances management and clinical development function with appointmen..
AQ
05/11Genentech Reports Interim Results for Phase III SKYSCRAPER-01 Study in PD-L1-High Metas..
BU
05/11Roche reports interim results for phase III SKYSCRAPER-01 study in PD-L1-high metastati..
AQ
05/10Kaiku Health enters a strategic partnership to further improve patient outcomes through..
AQ
05/10Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian A..
AQ
04/29New Three-Year Data for Genentech's Evrysdi (risdiplam) Show Long-Term Improvements in ..
BU
04/29New three-year data for Roche's Evrysdi (risdiplam) show long-term improvements in surv..
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares a..
AQ
04/28Affimed announces clinical update and trial in progress posters at the annual meeting o..
AQ
04/26Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
04/25Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 20..
AQ
04/22CHMP recommends EU conditional approval of Roche's potential first-in-class bispecific ..
AQ
04/22Chugai Adopts Snowflake Data Cloud to Accelerate Use of Internal Data across Company
AQ
04/07Oncolytics Biotech Letter to Shareholders - Update on Recent Progress
AQ
04/05U.S. FDA Grants Priority Review to Chugai's Actemra/RoActemra for the Treatment of COVI..
AQ
04/04U.S. FDA Grants Priority Review to Genentech's Actemra for the Treatment of COVID-19 in..
BU
04/04U.S. FDA grants priority review to Roche's Actemra/RoActemra for the treatment of COVID..
AQ
04/04New data for Roche's OCREVUS (ocrelizumab) show benefit in disability progression and c..
GL
04/04New Data for Genentech's Ocrevus (ocrelizumab) Show Benefit in Disability Progression a..
BU
03/30Genentech Provides Update on Phase III SKYSCRAPER-02 Study in Extensive-Stage Small Cel..
BU
03/29Chugai Pharmaceutical Co., Ltd. - Maruho Obtained Regulatory Approval for Mitchga, the ..
AQ
03/28CHMP recommends EU approval of Roche's Polivy combination for people with previously un..
AQ
03/25CHMP recommends EU approval of Roche's Polivy combination for people with previously un..
GL
03/25Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Ann..
GL
03/25Genentech to Present Data Across Broad and Impactful Neuroscience Portfolio at 2022 AAN..
BU
03/23Roche donates additional medicines and diagnostics for Ukraine
AQ
03/23Chugai Selected as a 'Nadeshiko Brand'
AQ
03/18Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
03/17AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomir..
AQ
03/16Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omi..
AQ
03/16New Data for Genentech's Evrysdi (risdiplam) Demonstrate Long-Term Efficacy and Safety ..
BU
03/16New data for Roche's Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a..
GL
03/15Ex-biotech executives sentenced for Genentech trade theft
AQ
03/15Chugai Pharmaceutical Co., Ltd. - Humanitarian Donation for Ukraine
AQ
03/15Roche Annual General Meeting 2022
AQ
03/15Roche Diagnostics India Earns the Frost & Sullivan 2021 India Competitive Strategy Lead..
AQ
03/10Chugai Pharmaceutical Co., Ltd. announced Personnel Changes
AQ
03/08Chugai Pharmaceutical Co., Ltd. - Filing of Humanized Anti-CD20 Monoclonal Antibody Gaz..
AQ
03/08Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular dis..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG